These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. You L; Qian W; Yang Q; Mao L; Zhu L; Huang X; Jin J; Meng H Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28507109 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China. Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216 [TBL] [Abstract][Full Text] [Related]
34. Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis. Rybak JM; Dickens CM; Parker JE; Caudle KE; Manigaba K; Whaley SG; Nishimoto AT; Luna-Tapia A; Roy S; Zhang Q; Barker KS; Palmer GE; Sutter TR; Homayouni R; Wiederhold NP; Kelly SL; Rogers PD Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630186 [TBL] [Abstract][Full Text] [Related]
35. Assessment of antifungal resistance and associated molecular mechanism in Candida albicans isolates from different cohorts of patients in North Indian state of Haryana. Kumar A; Nair R; Kumar M; Banerjee A; Chakrabarti A; Rudramurthy SM; Bagga R; Gaur NA; Mondal AK; Prasad R Folia Microbiol (Praha); 2020 Aug; 65(4):747-754. PubMed ID: 32219719 [TBL] [Abstract][Full Text] [Related]
36. Molecular Mechanisms of Azole Resistance in Four Clinical Shi H; Zhang Y; Zhang M; Chang W; Lou H Microb Drug Resist; 2021 Dec; 27(12):1641-1651. PubMed ID: 34037478 [TBL] [Abstract][Full Text] [Related]
37. UPC2 mutations and development of azole resistance in Candida albicans hospital isolates from Lebanon. Fattouh N; Hdayed D; Hijazi A; Tokajian S; Khalaf RA J Glob Antimicrob Resist; 2024 Sep; 38():341-348. PubMed ID: 39059553 [TBL] [Abstract][Full Text] [Related]
38. Pan-azole-resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11. Moreau J; Noël T; Point K; Tewes F; Deroche L; Clarhaut J; Fitton-Ouhabi V; Perraud E; Marchand S; Buyck JM; Brunet K Mycoses; 2024 Mar; 67(3):e13704. PubMed ID: 38429226 [TBL] [Abstract][Full Text] [Related]
39. Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications. Forastiero A; Mesa-Arango AC; Alastruey-Izquierdo A; Alcazar-Fuoli L; Bernal-Martinez L; Pelaez T; Lopez JF; Grimalt JO; Gomez-Lopez A; Cuesta I; Zaragoza O; Mellado E Antimicrob Agents Chemother; 2013 Oct; 57(10):4769-81. PubMed ID: 23877676 [TBL] [Abstract][Full Text] [Related]
40. Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans. Morio F; Pagniez F; Besse M; Gay-andrieu F; Miegeville M; Le Pape P Int J Antimicrob Agents; 2013 Nov; 42(5):410-5. PubMed ID: 24051054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]